Divalproex sodium delayed release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures; as sole and adjunct therapy for patients
The results demonstrated from the study indicated that QFT had a predictive value for developing TB disease of 15%, more than 6 times greater than the 2.3% for
The Phase I clinical trial, designed as a dose-escalation study to test the safety of NP2 will be conducted at the University of Michigan in Ann Arbor. In
The purpose of the study is to evaluate the effectiveness and clinical outcomes of Memo 3D when used to repair a diseased or dysfunctional mitral valve. The open
Under the terms of the transaction, company plans to acquire all the assets of Ion Metrics, including its mass spectrometer (MS) technology, differential mobility spectrometer (DMS) technology, ion
The trial will evaluate the efficacy and safety of INGN 225 in as many as 80 patients with extensive stage SCLC at multiple centers. Patients with SCLC have
The new equity investments were made by existing investors, including New Enterprise Associates, National Healthcare Services, Red River Ventures and Chisholm Private Capital. The debt financing was provided
Currently, Rich Whitney is founder and managing member of Whitney Capital and also serves as a Venture Partner with New Enterprise Associates. Previously, Mr.Whitney served as CFO of
Under this designation, Boehringer Ingelheim will conduct a pivotal trial program in a patient group where prior treatment with reversible EGFR inhibitors has failed. Andreas Barner, member of
Under the terms of the distribution agreement BodyTel granted TeleHealth Services the right to exclusively market the products of BodyTel in The Netherlands and non-exclusive in Belgium for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.